ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163949 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163949; 2) Community: the network communities that were significantly associated with the response to NSC 163949; 3) Molecule: the relationships between components within communities and NSC 163949; 4) MDR: the compounds that were significantly associated with the NSC 163949.

NSC Compound Enrichment Correlation
NSC 668483 Null 0.00361053534040666 -0.12376461
NSC 734235 isoindolo[1,2-a]quinoxalin-4(5H)-one 0.00361053534040666 0.038485413
NSC 104801 Cytembena 0.00485717408280859 -0.031079837
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.00485717408280859 -0.15054371
NSC 374980 Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- 0.00485717408280862 -0.091317129
NSC 624191 Null 0.00485717408280862 0.070917827
NSC 629971 Camptothecin Derivative 0.00485717408280862 0.059032468
NSC 651415 Dysorone E 0.00485717408280862 -0.079311923
NSC 697540 Null 0.00485717408280862 0.19760426
NSC 699150 Null 0.00485717408280862 0.1975417
Total:73  Current:8    [First] [Prev] [Next] [Last]